Home›Stock Screener›Modern Diagnostic & Research Centre

Modern Diagnostic & Research Centre Share Price Today | Stock Price & Modern Diagnostic & Research Centre Share Screener

MDRC Healthcare Services

Track the current Modern Diagnostic & Research Centre share price and stock price live with TickJournal's free stock screener. Track MDRC company valuation to gauge the company's total market size. Use the Modern Diagnostic & Research Centre stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Modern Diagnostic & Research Centre opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Modern Diagnostic & Research Centre Market Cap ₹82.90 Cr.
MDRC P/E Ratio (TTM) -
Modern Diagnostic & Research Centre P/B Ratio 1.42
EPS (TTM) ₹3.48
Dividend Yield -
Debt to Equity 0.75
MDRC 52 Week High -
Modern Diagnostic & Research Centre 52 Week Low -
Operating Margin -
Profit Margin -
MDRC Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹119.00
Total Equity ₹59.00

Modern Diagnostic & Research Centre Share Price Chart

Track the current stock price of Modern Diagnostic & Research Centre with an interactive chart. Analyse MDRC share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Modern Diagnostic & Research Centre stock quote in one place.

Modern Diagnostic & Research Centre Company Profile - Fundamental Screener

Screen Modern Diagnostic & Research Centre company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MDRC shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE1HK501016.

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

ISIN INE1HK501016

Modern Diagnostic & Research Centre Balance Sheet Screener

Screen MDRC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹119, up from ₹65 in 2025.

Latest statistics put total assets at ₹119 and shareholder funds at ₹59, with a leverage ratio of 0.75.

Item 2026 2025 2024 2023 2022

Assets

Total Assets 119 65 50 37 49
Current Assets 0 0 0 0 0
Fixed Assets 48 31 27 24 24

Liabilities

Total Liabilities 0 0 0 0 0
Current Liabilities 17 12 14 9 17
Non-Current Liabilities 0 0 0 0 0

Shareholders' Equity

Total Equity 59 21 12 6 12
Share Capital 15 11 1 1 1
Reserves & Surplus 43 10 11 5 11

Modern Diagnostic & Research Centre Income Statement Screener - Profit & Revenue Analysis

Screen Modern Diagnostic & Research Centre income statement and profit fundamentals. Analyze MDRC quarterly results. Modern Diagnostic & Research Centre reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹84 and net profit of ₹5.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March

Revenue and Expenses

Revenue 0 84 79 69 57 61
Expenses 0 71 60 56 57 54

Operating Costs and Margins

EBITDA 0 14 19 13 -1 6
Operating Profit % 0.00% 15.00% 23.00% 16.00% -2.00% 10.00%
Depreciation 0 5 4 4 4 4
Interest 0 2 2 2 1 2

Profit and Earnings

Profit Before Tax 0 6 13 7 -6 1
Tax 0 1 4 1 0 3
Net Profit 0 5 9 6 -6 -2
EPS 0.00 3.48 8.19 5.27 -5.21 -1.32

Modern Diagnostic & Research Centre Cash Flow Screener - Liquidity Fundamentals

Screen MDRC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹4, and net cash flow was an inflow of ₹9.

Over the same period, investing activities used ₹40 and financing activities provided ₹45.

Item 2026-March 2025-March 2024-March 2023-March 2022-March

Cash from Operations and Investing

Operating Activities 4 14 8 0 4
Investing Activities -40 -13 -11 2 -5

Financing and Net Cash

Financing Activities 45 0 3 -7 5
Net Cash Flow 9 0 0 -5 3

Modern Diagnostic & Research Centre Shareholding Pattern Screener

See Modern Diagnostic & Research Centre shareholding pattern with promoter, FII, and DII holdings. Check Modern Diagnostic & Research Centre promoter holding and ownership changes for MDRC on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jan, promoters held 72.85%, foreign institutions 1.07%, domestic institutions 11.80% and the public 12.82%, spread across 641 shareholders.

The shareholder count was 641 in 2026-Jan, compared with 282 in 2026-Mar.

Item 2026-Jan 2026-Mar 2026-Sept 2025-Mar 2025-Dec 1899-Dec

Promoter Holding

Promoter Holding 72.85% 72.85% 72.95% 100.00% 100.00% 72.85%

Institutional Investors

FII Holding 1.07% 0.03% 0.00% 0.00% 0.00% 1.07%
DII Holding 11.80% 15.48% 12.57% 0.00% 0.00% 11.80%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 12.82% 4.75% 7.32% 0.00% 0.00% 12.82%
Other Holding 1.45% 6.89% 7.16% 0.00% 0.00% 1.46%
Shareholder Count 641 282 393 7 7 641

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Modern Diagnostic & Research Centre. Modern Diagnostic & Research Centre dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Modern Diagnostic & Research Centre.

Modern Diagnostic & Research Centre Stock Index Membership - Nifty & Sensex

See which indices include Modern Diagnostic & Research Centre stock. Check MDRC index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Modern Diagnostic & Research Centre is not part of any tracked indices.
Only major market indices are tracked in our system.

Modern Diagnostic & Research Centre Market Events Screener - Corporate Actions

Get Modern Diagnostic & Research Centre corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Modern Diagnostic & Research Centre stock events that may affect MDRC share price, along with derivatives, futures and options activity and sector gainers.

2 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-30 2026-09-30 Annual General Meeting NA 41.21%
2026-05-29 2026-05-29 Quarterly Result Announcement NA -1.46%

Modern Diagnostic & Research Centre Competitors Screener - Peer Stocks Comparison

Screen MDRC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 125,272 53.50 25,420 15.58% 2,003 61.89
Max Healthcare Institute 100,339 72.60 8,536 18.82% 1,442 76.17
Manipal Health Enterprises 92,333 105.70 10,521 25.80% 917 60.80
Aster DM Quality Care 64,325 114.20 4,769 11.25% 427 57.55
Fortis Healthcare 60,910 57.30 9,179 16.93% 1,064 57.30
Narayana Hrudayalaya 38,984 45.30 7,996 43.43% 811 61.49
Global Health 38,831 63.30 4,509 19.56% 554 64.64
Dr. Lal Path Labs 33,237 56.50 2,864 12.11% 510 54.28
Krishna Institute of Medical Sciences 32,269 163.70 3,931 28.16% 242 66.73
Syngene International 17,533 94.20 3,809 2.56% 317 61.78

Modern Diagnostic & Research Centre Company Announcements - News & Reports Screener

Screen MDRC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated .

The next most recent announcements are dated November 18, 2026 and November 18, 2026.

Date Update Actions
Announcement under Regulation 30 (LODR)-Monitoring Agency Report -
2026-11-18 Financial Results For The Half Year Ended 30.09.2026 -
2026-11-18 Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 & 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-11-06 Compliances-Reg. 50 (1) - Prior intimation about Board meeting under Regulation 50(1) -
2026-10-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-01 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-30 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-28 Closure of Trading Window -
2026-09-15 Clarification On Significant Movement In The Price Of The Securities Of The Company -
2026-09-15 Clarification sought from Modern Diagnostic & Research Centre Ltd -
2026-09-06 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-05 Reg. 34 (1) Annual Report. -
2026-09-05 Revised Letter Attached In The Intimation For 14Th AGM Of The Company -
2026-09-05 Revised Date In The Letter Attached For Intimation Of Book Closure -
2026-09-05 Revised Date In The Letter Attached For Intimation Of Record Date -
2026-09-03 Intimation For The 14Th Annual General Meeting (AGM) And Book Closure -
2026-09-03 Intimation For The 14Th Annual General Meeting (AGM) And Book Closure -
2026-09-03 Intimation For Record Date -
2026-09-03 Intimation Of Appointment Of Scrutinizer Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (LODR) -
2026-09-03 Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 & 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 1.42. Market capitalisation stands at ₹82.90 Cr. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on November 21, 2026. This page covers 5 balance sheet periods, 6 income statement periods, 5 cash flow years and 6 shareholding periods. Information is provided for research and is not investment advice.